Decoy Therapeutics Inc. Common Stock (DCOY)
Stock · NASDAQ · Health Care
$1.17as of 10/16/2026
Price chart
Active signals
DCOY Signal Track Record
How signals performed across all stocks →What DCOY's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakdown | 23 | -1.5% | 48% | September 30, 2026 |
| Bollinger Band Breakout | 20 | -19.3% | 5% | September 23, 2026 |
| Volume Spike | 10 | -28.2% | 10% | September 9, 2026 |
| Any 20-session window (baseline) | -10.8% | 31% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About DCOY
Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that leverages peptide coiled-coils chemistry and physics to design a-helical peptides through computational and ML tools. The company's IMP3ACT platform leverages machine learning an…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 11
- Website
- salariuspharma.com/
Fundamentals
- 1-day range
- $1.61$1.88
- Market cap
- $2.40M
- P/E (trailing)
- —
- P/E (forward)
- -0.20
- EPS (trailing)
- $-934.89
- Dividend yield
- —
- Beta
- 0.69
- Avg. volume
- 2.19M
Forecasts
1 analyst ratings
Decoy Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- DCOYDecoy Therapeutics Inc. Common Stock$1.17▼ 4.88%Market cap $2.40MP/E —$2.01$55.92
- OGENOragenics Inc. Common Stock$0.43▼ 2.27%Market cap $2.45MP/E 0.56$0.43$1.45
- PPBTPurple Biotech Ltd. American Depositary Shares$1.14▼ 7.32%Market cap $2.29MP/E —$1$2.2
- CDTCDT Equity Inc. Common Stock$0.235▲ 12.44%Market cap $2.54MP/E —$0.1813$28,125
- GNPXGenprex Inc. Common Stock$2.11▼ 7.86%Market cap $2.24MP/E —$2.53$1,210
- AZTRAzitra Inc Common Stock$0.072▲ 0.00%Market cap $2.18MP/E 6.22$0.0518$1.09
- ARTLArtelo Biosciences Inc. Common Stock$2.7▼ 1.46%Market cap $2.62MP/E —$2.92$179.19
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| DCOY Decoy Therapeutics Inc. Common Stock | $2.40M | — | $1.17 | ▼ 4.88% | $2.01$55.92 |
| OGEN Oragenics Inc. Common Stock | $2.45M | 0.56 | $0.43 | ▼ 2.27% | $0.43$1.45 |
| PPBT Purple Biotech Ltd. American Depositary Shares | $2.29M | — | $1.14 | ▼ 7.32% | $1$2.2 |
| CDT CDT Equity Inc. Common Stock | $2.54M | — | $0.235 | ▲ 12.44% | $0.1813$28,125 |
| GNPX Genprex Inc. Common Stock | $2.24M | — | $2.11 | ▼ 7.86% | $2.53$1,210 |
| AZTR Azitra Inc Common Stock | $2.18M | 6.22 | $0.072 | ▲ 0.00% | $0.0518$1.09 |
| ARTL Artelo Biosciences Inc. Common Stock | $2.62M | — | $2.7 | ▼ 1.46% | $2.92$179.19 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Unusual volume stocks in Wednesday's sessionChartMill · 9/23/2026
- Wednesday's session: top gainers and losersChartMill · 9/23/2026
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga · 9/23/2026
- Stay updated with the stocks that are on the move in today's pre-market session.ChartMill · 9/23/2026
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga · 9/23/2026
- Why Worthington Enterprises Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving PremarketBenzinga · 9/23/2026
- Decoy Therapeutics, Inc. Issues Correction to Warrant Inducement Transaction Press ReleaseYahoo · 9/22/2026
- /C O R R E C T I O N -- Decoy Therapeutics, Inc/Yahoo · 9/22/2026
Insider Activity
Insider Actions →- Gauthier Patricia G. · August 31, 2026 · Grant2.0K
- Marschel Peter Klaus · August 31, 2026 · Grant3.9K
- Hibner Barbara Louise · August 31, 2026 · Grant4.2K
- Burleson Tess · August 31, 2026 · Grant2.0K
- McVicar William K. · August 31, 2026 · Grant3.0K
- Lammers Paul · August 31, 2026 · Grant2.0K
- Lieber Jonathan I · August 31, 2026 · Grant2.0K
- Rosenblum Mark J · August 31, 2026 · Grant9.7K
- HANISH ARNOLD C · August 31, 2026 · Grant3.0K
- PIERCE FREDERICK II · August 31, 2026 · Grant33.5K
Institutional Ownership
March 31, 2026
- Total shares held
- 1.6K
- Total value held
- $10.5K
- Institutional holders
- 4
- Unknown1.0K
- Unknown546
- Unknown41
- Unknown1
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
DCOY Reports Preclinical Data for Once-Weekly Dosing
Decoy Therapeutics released preclinical data supporting a once-weekly intranasal dosing schedule for its DCOY-CoV program. The company is also scheduled to present at The Small Cap Showcase investor conference. These updates provide context for the stock's current trading levels, which sit near significant support.
DCOY Reports Preclinical Data for Once-Weekly Dosing. Decoy Therapeutics released preclinical data supporting a once-weekly intranasal dosing schedule for its DCOY-CoV program. The company is also scheduled to present at The Small Cap Showcase investor conference. These updates provide context for the stock's current trading levels, which sit near significant support.